Health
Modified version of CAR T-cell therapy shows promise in targeting neuroblastoma – News-Medical.Net
Chimeric Antigen Receptor T-cell therapy–CAR T–has revolutionized leukemia treatment. Unfortunately, the therapy has not been effective for treating solid tumors…
Chimeric Antigen Receptor T-cell therapy–CAR T–has revolutionized leukemia treatment. Unfortunately, the therapy has not been effective for treating solid tumors including childhood cancers such as neuroblastoma. Preclinical studies using certain CAR T against neuroblastoma revealed toxic effects.
Now, a group of scientists at Children’s Hospital Los Angeles have developed a modified version of CAR T that shows promise in targeting neuroblastoma, spares healthy brain tissue and more effectively…
-
Noosa News21 hours agoTributes for woman allegedly mowed down on footpath in Maroochydore; Guilherme Dal Bo charged
-
General14 hours agoTwo people arrested after man fatally shot at McLaren Flat
-
General18 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat
-
General7 hours agoThe one tweak that could grow your super by $200,000